A summary of the recent Duke Climate Collaboration Symposium focused has been published! Co-hosted by Duke-Margolis & the School of Medicine, the event convened leaders across disciplines to explore how the health care landscapes can adapt and lead in the face of a changing climate: duke.is/w/yu9h

Duke-Margolis researchers Montgomery Smith and Frank McStay co-authored a paper in the Journal of the American Medical Directors Association that studied stakeholder feedback on the potential development of a home-based primary care practice recognition program: duke.is/n/tvd2

Join us this Thursday for our hybrid workshop, "Individualized Therapies on the RISE." In this second installment of the FDA's RISE workshop series, speakers will explore the emerging science and regulatory environment for individualized medicine programs. Registration closes soon: duke.is/m/jxxj

Mark McClellan discussed how health care leaders can build a more sustainable future during the 2025 Health Evolution Summit. Learn more about Mark's and his fellow speakers' thoughts in the Summit recap: duke.is/m/zntv

Our next event is days away! Join us on November 18 for a webinar that will explore how to build a sustainable, value-driven roadmap for HBPC within Medicare. Registration closes soon, so don't forget to secure your spot in the conversation: duke.is/9/ct26

Duke-Margolis researchers have co-authored a paper in the North Carolina Medical Journal to discuss the history of bipartisan support for NC Medicaid, highlight examples of lessons learned and impacts, and offer key considerations for the path forward. Read more here: duke.is/r/gge5

With the homebound population growing, how do we build the roadmap for better home-based primary care? A draft agenda is now available for our upcoming webinar, where speakers will explore solutions to this question. Join us on November 18 for this important conversation: duke.is/9/ct26

Hear from Assistant Research Director Frank McStay next week at the PCC's 2025 Evidence Report release! On 11/12, Frank and his fellow speakers will examine the state of rural primary care as residents of rural communities face new barriers to health coverage: thepcc.pub/Closing-The-Distance

In this new Health Affairs Forefront article, Duke-Margolis researchers explore opportunities to advance rapid learning for accountable care. In particular, they highlight the potential of collaborative action through efforts like the new West Health Accelerator at Duke-Margolis: duke.is/r/w5uz

Duke-Margolis has published an event report for "On the RISE: Controls in Rare Disease Clinical Trials for Small and Diminishing Populations" that summarizes the discussion that took place, offers key takeaways, and outlines next steps. You can read it here: duke.is/z/mkv3

Don't miss your chance to join this conversation! Tomorrow, we are gathering health policy experts and leaders across the public and private sectors to discuss the vision for accountable care reform, and chart a path toward delivering better health and better care for all: duke.is/p/3vx6

Drug shortages have severely impacted patient care in the U.S. for decades. In our latest white paper, Duke-Margolis researchers propose next steps that Congress can take to address the root causes of the drug shortage problem + create a more reliable & resilient supply chain: duke.is/6/mduj

Institute Director Mark McClellan and Policy Analyst Sara Debab have co-authored a new Viewpoint article in JAMA Health Forum to outline steps that reduce clinician burnout by modernizing Medicare’s risk adjustment mechanism. Read their recommendations here: duke.is/w/tdna

A new event has been announced! Don't miss this webinar coming up on November 18, where speakers will explore opportunities to advance home-based primary care. Learn more and register here: duke.is/9/ct26

@michellescotton.bsky.social @dukemargolis.bsky.social sharing our engagement project learnings with researchers and patient advocates at #PCORI25

Learn more about the current state and future of the Sentinel Initiative in our upcoming workshop, convened with the FDA. A draft agenda is now available and contains more details about the topics of discussion—you can read it and register to attend here: duke.is/z/wdhk

A draft agenda is now available for our upcoming workshop, "Individualized Therapies on the RISE"! Co-convened with the FDA, this event will explore the regulatory considerations surrounding individualized therapies that can help treat rare diseases. Read the agenda + register here: duke.is/m/jxxj

Our next event is just around the corner! We invite you to join us in DC for a timely conversation on accountable care reform. With new technological advances, policy shifts, and the lessons learned from the last decade, the next chapter of accountable care starts now: duke.is/p/3vx6

A new hybrid workshop has been announced! Join us at the Duke in DC office on December 16 as speakers discuss ways to expand epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and mortality. Learn more and register here: duke.is/y/x7xs

Don't miss our Open House this Friday! Join us in our Durham office to learn more about how the Institute's research and educational initiatives help engage students across campus in health policy. We're hosting this event as part of Duke's Family Weekend: duke.is/n/x6w2

In just a few weeks, we are hosting the Seventeenth Annual Sentinel Initiative Public Workshop with the FDA. Join us at the FDA's White Oak Campus in Maryland to learn more about the initiative's work so far as well as future directions. Register today: duke.is/z/wdhk

Join us in DC for a new workshop, "Individualized Therapies on the RISE," coming up on November 20. During this event, speakers will examine the emerging science and regulatory environment for individualized medicine programs. Learn more and register here: duke.is/m/jxxj

Join us next Friday, 10/ 17, for our Open House! This event is an opportunity to meet the educators and mentors who are working with Duke students, and to learn more about how the Institute's research and educational initiatives help engage students across campus in health policy: duke.is/n/x6w2

Don't miss this upcoming event! On November 6, we are hosting the Seventeenth Annual Sentinel Initiative Public Workshop with the FDA. Each year, this event showcases the work of the Sentinel Initiative to-date, along with future-looking discussions: duke.is/z/wdhk

Accountable care—centered on personalized, coordinated, and whole-person care—is no longer the vision for the future of the American Health system: it is here, now. Join us next month for an event that will launch the new West Health Accelerator at Duke-Margolis: duke.is/p/3vx6

Don't miss the upcoming Duke Climate Collaboration Symposium! On 10/1, speakers will explore opportunities to reduce health care greenhouse gas emissions and implement reforms to mitigate the health impacts of climate change: duke.is/y/s33v

CMS Administrator Mehmet Oz and Duke-Margolis Director Mark McClellan will discuss CMS' vision and strategies during an upcoming event hosted by The Aspen Institute. Join in-person or virtually next Wednesday, September 24, to learn more! You can register to attend here: duke.is/b/49j5

Join us tomorrow for our next hybrid workshop! Speakers will explore novel efficacy endpoints used in interventional clinical trials for drugs and biological products intended for patients with severe vision loss. A discussion guide is now available—you can read it and register here: duke.is/6/jzzn

In our newest white paper, Duke-Margolis researchers share policy recommendations to strengthen drug supply chain security and resilience, including through the establishment of an international biopharmaceutical coalition. Read more here: duke.is/j/pevx

On 10/7, the Duke Center of Global Mental Health is hosting their 2025 conference, "Now More than Ever: Addressing the Global Imperative of Mental Health Equity." Registration is free and all are welcome to attend: sites.duke.edu/dukegmhconf2025/

📣JUST PUBLISHED: Our white paper on regulatory opportunities to advance generic drug repurposing is now available online! This paper explores the role of the regulator and policy actions it can take to support repurposing initiatives. @dukemargolis.bsky.social healthpolicy.duke.edu/publications...

Duke-Margolis researchers have co-authored a paper in the Journal of Pharmacy & Pharmaceutical Sciences on pharmacogenomics (PGx) testing data. They noted that improving racial and genetic ancestry data, and increasing interoperability with EHRs, could make PGx data more actionable: duke.is/5/ygcs

Don't miss your chance to register! Next Wednesday, September 3, we're hosting a workshop with the FDA to discuss control options in rare disease clinical trials. A final agenda and speaker bios have been posted to the event webpage—you can read them and register here: duke.is/z/mkv3

Speakers have been announced for our upcoming virtual workshop! On 9/10, hear from FDA officials and health policy experts as we discuss challenges and strategies for expedited chemistry, manufacturing, and controls development. Learn more about our speakers and register here: duke.is/n/eef3

Our next event is right around the corner! On 9/3, we're hosting a hybrid workshop with the FDA to explore control options for rare disease clinical trials. Though we have reached capacity for in-person registration, we invite you to join the waitlist or register to attend virtually: duke.is/z/mkv3

A draft agenda is now available for our workshop on 9/17, where speakers will discuss clinical trial endpoints for drugs and biological products intended for patients with severe vision loss. Join us in DC to discuss this critical topic and network with your peers: duke.is/6/jzzn

Join FDA & Duke-Margolis Sept. 23 at the National Press Club for a free, hybrid public workshop that will discuss examples in which real-world evidence was used for regulatory decision-making for medical products. Register today: duke.is/y/7nyz

Hear from Institute Director Mark McClellan at a special edition of the Virtual Value-Based Payment Summit. Mark and his fellow speakers will discuss the future of Medicare value-based care during the closing fireside chat on 9/5. Learn more and register here: valuebasedpaymentsummit.com/

Looking for practical ways to use data for impact? The breakout session “Mosaic in Motion” at #hdpalooza showcases tools and case studies that bring health data to life. See session details: buff.ly/eNJoqM4 Learn from researchers from @dukemargolis.bsky.social and more. Will we see you Sept 5?

Hear from Senior Research Director Rob Saunders at #HDPalooza on September 5 as he discusses West Health's new health data platform during the breakout session, "Mosaic in Motion: Exploring New Tools for Turning Data into Action." Learn more and register here: academyhealth.org/Datapalooza

Registration closes soon! Join us tomorrow for our virtual meeting, the State of Real-World Evidence Policy 2025, to learn more about our current strategic plan and vision for advancing real-world evidence policy across several areas of health care. Read the agenda and register here: duke.is/p/bkhe

A new hybrid workshop has been announced! Join us on September 17 for this event, convened under a cooperative agreement with the FDA, where speakers will explore endpoints for interventional clinical trials focused on ophthalmologic rare disease treatments. Register here: duke.is/6/jzzn

Join us on September 10 for a virtual #healthpolicy workshop, hosted in collaboration with the FDA, that will explore challenges and strategies for expedited chemistry, manufacturing, and controls development. Learn more and register here: duke.is/n/eef3

On 9/3, we're hosting a hybrid #healthpolicy workshop with the FDA to explore considerations when choosing controls in #raredisease #clinicaltrials, particularly for small and diminishing populations. Read the draft agenda and register here: duke.is/z/mkv3

Duke-Margolis researchers have published a new #healthpolicy paper in the North Carolina Medical Journal that examines state initiatives to address health-related social needs (HRSNs) and identifies opportunities to advance these efforts: duke.is/p/qbem

Don't miss out! On 7/31, speakers will explore current + future opportunities for #RWD & #RWE, including how to better integrate research into care, guide payer coverage, shape the international regulatory policy landscape, & support regulatory-decision making: duke.is/p/bkhe

We are excited to share our students’ great work at the Duke Summer Research Showcase on July 25. Stop by Trent Semans Great Hall between 10am - 12pm to meet our students and learn more about their research this summer. The event is free to attend, and registration is not required: duke.is/y/5yvm

If you missed our meeting on the North Carolina State Transformation Collaborative, watch the highlights in our latest Rapid Recap video! www.youtube.com/watch?v=Gfa4...

We've released a new white paper! Investing in a powerful, limited set of shared data elements and interoperability of tools can enhance the availability, quality, and connectivity of longitudinal patient data for better outcomes, faster discoveries, and smarter spending: duke.is/5/4rpu

Join us for our next event, "The State of Real-World Evidence Policy 2025," as we discuss strategic real-world data and real-world evidence (RWD/E) policy developments, promising future applications of RWD/E, and recent Duke-Margolis RWE Collaborative activities: duke.is/p/bkhe